Preparation and Quality Evaluation of Chloramphenicol Solid Lipid Nanoparticles
Hua Huang
Abstract
Hua Huang
Abstract
OBJECTIVE:To prepare Chloramphenicol solid lipid nanoparticles(CAP-SLN) and to study the quality of it.METHODS:The preparation technilogy of CAP-SLN was optimized by orthogonal test with the entrapment efficiency and drug loading amount as index and with proportion of CAP to Precirol ATO 5(drug-to-lipid ratio),amount of poloxamer,emulsifying temperature,volume ratio of emulsion-disperse phase as factors.CAP-SLN was prepared by emulsification evaporation-low temperature solidification technique.The quality of preparation was evaluated with particle size,Zeta potential,drug-loading amount,stability and in vitro drug release rate as index.RESULTS:The optimal formulation was as follows:drug-to-lipid ratio of 1:10,the weight of poloxamer of 2%,emulsifying temperature of 70 ℃,drug-to-lipid of 1:7.The mean diameter of CAP-SLN was 227 nm.The zeta potential was-30.5 mV.The entrapment efficacy was 65.9%.The average drug-loading amount was 6.59%.CAP-SLN could keep stable at 4 ℃ at least for one month.The entrapment efficacy of CAP-SLN at 25 ℃ decreased significantly while particle size increased.The burst release of CAP-SLN was found during the former 4 h.The drug release rate of it was 58.86% at 4 h and reached 85.09% at 48 h.The in vitro drug release behavior was in line with Weibull equation.CONCLUSION:The preparation technique and formulation are practicable.CAP-SLN is up to quality standard and can achieve sustained-release effects.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To prepare Chloramphenicol solid lipid nanoparticles(CAP-SLN) and to study the quality of it.METHODS:The preparation technilogy of CAP-SLN was optimized by orthogonal test with the entrapment efficiency and drug loading amount as index and with proportion of CAP to Precirol ATO 5(drug-to-lipid ratio),amount of poloxamer,emulsifying temperature,volume ratio of emulsion-disperse phase as factors.CAP-SLN was prepared by emulsification evaporation-low temperature solidification technique.The quality of preparation was evaluated with particle size,Zeta potential,drug-loading amount,stability and in vitro drug release rate as index.RESULTS:The optimal formulation was as follows:drug-to-lipid ratio of 1:10,the weight of poloxamer of 2%,emulsifying temperature of 70 ℃,drug-to-lipid of 1:7.The mean diameter of CAP-SLN was 227 nm.The zeta potential was-30.5 mV.The entrapment efficacy was 65.9%.The average drug-loading amount was 6.59%.CAP-SLN could keep stable at 4 ℃ at least for one month.The entrapment efficacy of CAP-SLN at 25 ℃ decreased significantly while particle size increased.The burst release of CAP-SLN was found during the former 4 h.The drug release rate of it was 58.86% at 4 h and reached 85.09% at 48 h.The in vitro drug release behavior was in line with Weibull equation.CONCLUSION:The preparation technique and formulation are practicable.CAP-SLN is up to quality standard and can achieve sustained-release effects.
Key concepts: Solid lipid nanoparticle, Zeta potential, Chromatography, Particle size, Chemistry, Poloxamer, Drug, Emulsion